WMSA
Weiss Multi-Strategy Advisers’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-30,000
| Closed | -$570K | – | 713 |
|
|
2022
Q2 | $570K | Buy |
30,000
+22,500
| +300% | +$428K | 0.02% | 521 |
|
|
2022
Q1 | $202K | Buy |
+7,500
| New | +$202K | ﹤0.01% | 605 |
|
|
2021
Q3 | – | Sell |
-7,043
| Closed | -$225K | – | 742 |
|
|
2021
Q2 | $225K | Buy |
+7,043
| New | +$225K | ﹤0.01% | 585 |
|
|
2021
Q1 | – | Sell |
-8,434
| Closed | -$270K | – | 760 |
|
|
2020
Q4 | $270K | Buy |
8,434
+434
| +5% | +$13.9K | 0.01% | 586 |
|
|
2020
Q3 | $301K | Buy |
+8,000
| New | +$301K | 0.01% | 493 |
|
|
2020
Q2 | – | Sell |
-9,225
| Closed | -$315K | – | 580 |
|
|
2020
Q1 | $315K | Sell |
9,225
-3,775
| -29% | -$129K | 0.01% | 356 |
|
|
2019
Q4 | $507K | Buy |
+13,000
| New | +$507K | 0.01% | 463 |
|